TickerFacts.

iSpecimen Inc. (ISPC): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$4.24M
Year ended 2025-12-31
-$7.00M
Trailing 12 months to 2026-06-30
2020-12-31: -$288.4K2021-12-31: -$10.67M2022-12-31: -$5.82M2023-12-31: -$5.81M2024-12-31: -$8.26M2025-12-31: -$4.24M-$4.24M
2020-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$4.24Mn/m2026-04-01, From 2025-01-01
2024-12-31-$8.26Mn/m2026-04-01, From 2024-01-01
2023-12-31-$5.81Mn/m2025-04-14, From 2023-01-01
2022-12-31-$5.82Mn/m2024-03-13, From 2022-01-01
2021-12-31-$10.67Mn/m2023-03-30, From 2021-01-01
2020-12-31-$288.4Kn/a2022-03-22, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
iSpecimen Inc. (ISPC)2025-12-31-$4.24Mn/m
OneMedNet Corp (ONMD)2025-12-31-$7.50Mn/m
Absci Corp (ABSI)2025-12-31-$92.92Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$9.33Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$329.6Kn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$3.87Mn/m
OmniAb, Inc. (OABI)2025-12-31-$36.45Mn/m
MaxCyte, Inc. (MXCT)2025-12-31-$34.41Mn/m
NRC Health (NRC)2025-12-31$26.45M-23.6%

Compare ISPC, ONMD, ABSI, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗